Position in LYEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,744,642
-$2,029,559 QoQ
Shares Held
337,697
0.0% QoQ
Ownership
1.38%
of shares outstanding
% of Portfolio
0.91%
of 13F equity value
Holder Rank
#11
of 87 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LYEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026venBio Partners LLC holds $519,380,252 across 7 Biotechnology names. LYEL ranks #7 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PHVS |
Pharvaris N.V.
|
4,643,430 | $160,569,809 | |
| 2 | PBLS |
Parabilis Medicines, Inc.
|
5,266,697 | $144,149,496 | |
| 3 | ALMS |
Alumis Inc.
|
4,528,408 | $127,429,401 | |
| 4 | ACHV |
Achieve Life Sciences, Inc.
|
5,914,720 | $38,623,121 | |
| 5 | ALXO |
Alx Oncology Holdings Inc
|
12,884,638 | $26,671,200 | |
| 6 | HRMY |
Harmony Biosciences Holdings, Inc.
|
472,194 | $17,192,583 | |
| 7 | LYEL |
Lyell Immunopharma, Inc.
This page
|
337,697 | $4,744,642 |
All Filings in LYEL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,744,642 | 337,697 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,774,201 | 337,697 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,394,313 | 337,697 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,689,298 | 473,479 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,185,554 | 473,479 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,820,978 | 7,102,190 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,545,401 | 7,102,190 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||